What Гемотест does

Гемотест (Gemotest) is a Russian private medical laboratory operator incorporated as ООО Лаборатория Гемотест, founded in 2002 and headquartered in Moscow. The company runs a direct-to-consumer diagnostic services business through a network of more than 1,200 owned and franchised laboratory branches spanning 639 cities across all Russian Federal Districts and extending into Central Asia (Kyrgyzstan, Kazakhstan, Uzbekistan, Tajikistan). Service lines cover clinical laboratory analyses (blood, urine, stool, saliva, microbiology), PCR diagnostics, genetic testing including NIPT non-invasive prenatal screening and full exome sequencing, medical imaging (ultrasound, ECG, Holter monitoring, ABPM, MRI), colposcopy, and complementary telemedicine consultations and home-visit sample collection.

The underlying technology is conventional clinical laboratory and diagnostic medicine; no proprietary AI/ML stack, digital platform architecture, or software product is disclosed in the input. Patient-facing infrastructure consists of the gemotest.ru catalog and personal account, a Telegram bot (@gemotestlab), MAX messenger integration, and social channels on VK, Odnoklassniki, and WhatsApp for engagement and result delivery. The Гемотест Live portal serves as the news and information channel, and a B2B shop at gemotest.shop supplies medical organizations.

Gemotest's revenue model is transactional: individual patients pay per test or screening package, with prices ranging from 250 RUB for basic screenings (e.g., glucose, liver, kidney, thyroid, basic panels) to 6,690+ RUB for comprehensive check-ups covering 39, 63, or 100 parameters. Home-visit venous blood draws carry an additional 330 RUB fee. The Гемотест Клуб + Бонус loyalty program adds up to 10% cashback on orders and underpins retention. Customer segments are primarily individual B2C patients, with a franchise program for healthcare organizations and a B2B partner program for medical institutions extending the reach of sample collection. A co-branded preventive-health campaign with RЖД-Медицина (RZD-Medicine), running July 1 to September 30, 2026, targets breast cancer screening via the railway healthcare network.

Name

Гемотест

Legal name

ООО Лаборатория Гемотест

Website

https://gemotest.ru

Company type

Private

Operating status

Operating

Headcount range

101–250 employees

Short description

Гемотест (Gemotest) is a Russian private medical laboratory operating 1,200+ owned and franchised branches across Russia and Central Asia, offering B2C clinical diagnostics, genetic testing, imaging, telemedicine, and home-visit sample collection to individual patients.

Ownership category

akta.pro rank

Product category

Medical Diagnostic Laboratory Services

NAICS

Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511), Diagnostic Imaging Centers (621512)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Genetic & Prenatal Testing Laboratories (HLAFAMAH)

akta.pro secondary industries

Urinalysis & Routine Screening Diagnostics (HLAHAAAG), Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home) (HSABACAN), Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD)

Keywords

• Medical laboratory services
• Diagnostic testing services
• Clinical laboratory diagnostics
• Preventive health screenings
• Genetic testing services

Headquarters

HQ city

Moscow

HQ country

Russia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Laboratory Testing Services: Transaction-based medical laboratory testing services where patients pay per individual test or screening package. Pricing varies by test complexity from 250 RUB for basic screenings to 6,690+ RUB for comprehensive check-ups.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Гемотест operates a nationwide network of medical diagnostic laboratories that performs clinical analyses (blood, urine, stool, saliva, genetic, PCR), imaging studies (ultrasound, ECG, Holter monitoring, MRI), colposcopy, non-invasive prenatal testing (НИПТ), and tiered check-up packages for individual patients. Services are accessed through 1,200+ physical branches across Russia and Central Asia, online ordering, telemedicine consultations, and a home-visit sample collection service.

Product overview

Гемотест is a medical laboratory offering a comprehensive suite of diagnostic and healthcare services. The core offering includes clinical laboratory tests (blood, urine, stool, saliva, genetic testing), medical imaging services (ultrasound, ECG/Holter monitoring), telemedicine consultations, and home visit sample collection. Key products include the NIPT (non-invasive prenatal testing), health screening packages (скрининги), comprehensive check-ups (чекапы), and the Гемотест Клуб loyalty program. The company operates through 639 branches across Russia with expansion into Central Asian markets. The portfolio integrates direct patient services (online consultation, home analysis) with laboratory diagnostics and genetic testing capabilities.

Differentiator

Problem solved

Functional benefit

Brands

• Гемотест Клуб + Бонус: Loyalty program offering personal discounts, special offers, and 10% cashback on orders
• Гемотест Live
• Гемотест Бонус

Products and services

• НИПТ (Non-invasive prenatal testing) Non-invasive prenatal testing service that screens for fetal chromosomal abnormalities including trisomies 21, 18, and 13, intended for expecting parents seeking early genetic risk assessment.
• Телемедицина (Telemedicine consultation) Online doctor consultation service providing medical recommendations and remote support, commonly used to interpret laboratory test results and guide patients, integrated with Gemotest's diagnostic offering.
• Выезд на дом (Home visit sample collection) Medical-staff home visit service that performs sample collection (blood, urine, etc.) at the patient's residence, with an additional fee of 330 RUB for venous blood collection, intended for home-bound, elderly, or mobility-limited patients.
• Скрининги организма (Basic body screenings) Entry-level screening packages starting from 250 RUB that assess basic health parameters including glucose, liver, kidney, heart and thyroid function, and full body check-up builds, intended for general consumers looking for affordable preventive screening.
• Генетические исследования (Genetic testing services) Genetic testing suite including non-invasive prenatal testing, genetic risk assessment for prospective parents, and complete exome sequencing for hereditary disease diagnosis, intended for individuals and couples planning a family or investigating hereditary conditions.
• Ультразвуковая диагностика (Ultrasound diagnostics) Ultrasound diagnostic imaging services covering various body systems, performed at Gemotest branches for individuals requiring non-invasive imaging assessment.
• ЭКГ, Холтер и СМАД (ECG, Holter and ABPM) Cardiac diagnostic services including standard electrocardiogram (ECG), 24-hour Holter monitoring, and ambulatory blood pressure monitoring (ABPM/СМАД), for individuals needing heart-rhythm and blood-pressure assessment.
• Чек-апы (Comprehensive check-up packages) Comprehensive multi-parameter health check-up packages offered in three sizes — 39, 63, and 100 parameters — for women, men, and children, providing a full body examination as a single bundled offering. Pricing starts from 6,690 RUB.

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• РЖД-Медицина (RZD-Medicine)coreStrategic or Co-development Partner · 1 July 2026Special project 'С заботой о тебе' (With care for you) focused on breast cancer prevention. Joint preventive healthcare initiative between Gemotest and RZD-Medicine railway healthcare network, running from July 1 to September 30, 2026.

Scale indicators2 records

Recent moves6 records

Expansion highlights3 records

Direct peers

• Helix Laboratory: Russian private medical laboratory chain offering clinical diagnostics, genetic testing, and home sample collection; competes directly with Gemotest in Moscow, St. Petersburg, and other major Russian cities with a comparable multi-channel consumer model.
• Invitro: Russia's largest private medical laboratory network; operates a similar B2C clinical lab model across Russia with comparable genetic, routine screening, and home-visit services — Gemotest's most direct head-to-head competitor.
• Center for Molecular Diagnostics (CMD): Russian medical laboratory specializing in PCR, infectious disease, and molecular diagnostics; overlaps with Gemotest's PCR and STI testing menu and serves a similar B2C patient base.
• KDL Laboratory: Russian clinical diagnostics chain with hundreds of branches offering blood work, PCR, genetic testing, and check-up packages; competes with Gemotest across regional Russian markets with similar B2C positioning.

Broad incumbents

• Eurofins Scientific: Global leader in clinical diagnostics and laboratory services with broad genetic, molecular, and routine testing capabilities; represents the upper bound of scale and sophistication against which Gemotest's regional lab chain competes.
• LabCorp (Laboratory Corporation of America): Major US-based clinical laboratory network with comprehensive diagnostics, genetic, and patient service center offerings; provides a benchmark for the B2B + B2C hybrid lab services model Gemotest could evolve toward.
• Quest Diagnostics: One of the largest global clinical laboratory networks offering routine and advanced diagnostics including genetic testing; comparable breadth of test menu and physician/health-system referral channels but operating at much larger scale with B2B contracts.

Regional players

• Synevo (Medicover): Eastern European clinical laboratory chain operating across Ukraine, Romania, Moldova, Bulgaria, and other CIS/CEE markets; comparable business model and consumer-facing lab services but focused on different geographies than Gemotest.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/gemotest

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Гемотест